Using a telemedicine system to engage people in underserved, urban communities to measure and report their blood pressure remotely — outside of the doctor’s office — appears to help them achieve blood pressure goals and improve adherence to lifestyle changes and medication recommendations. This is according to research being presented at the American College of Cardiology’s 62nd Annual Scientific Session. Overall, researchers say that just being in a system of care, with or without telemedicine, can result in important reductions in blood pressure.



Medtronic Inc. announced the U.S. Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) have accepted the inclusion of the Symplicity renal denervation system for treatment-resistant hypertension in their parallel review program, which will allow CMS to begin consideration for national coverage determination while the FDA completes its review of safety and efficacy.


With the recent release of the updated American Heart Association (AHA)/American Stroke Association (ASA) Guidelines for Early Management of Acute Stroke Patients, Physio-Control announced that the LifeNet System’s OnePush feature can be used to rapidly activate stroke care teams. LifeNet’s stroke alert capability enables faster time-to-treatment, assisting stroke care teams in meeting the updated AHA/ASA Guidelines and helping improve stroke patient outcomes. The updated guidelines, released Jan. 31, 2013, support the overarching concept of stroke systems of care and detail aspects of stroke care from patient recognition; emergency medical services activation, transport and triage; through the initial hours in the emergency department and stroke unit.[1]

 

March 11, 2013 — HealthHelp announced it will launch in select markets in May its MedTree QDS, a transparent clinical decision support (CDS) system that allows providers to self-govern the ordering process and receive approval for a test or procedure in less than one minute.

Royal Philips Electronics and Infraredx Inc. announced the availability of a new solution that enables seamless access to Infraredx’s true vessel characterization (TVC) Imaging System via Philips’ Allura Xper catheterization (cath) lab imaging systems. The product offering ensures compatibility between the two systems and allows clinicians to quickly and easily connect the TVC Imaging System to the Allura Xper system when intravascular imaging is required as part of cardiac catheterization procedures.

 


Even minor weight loss is associated with worse health outcomes among patients implanted with a certain type of defibrillator known as cardiac resynchronization therapy with defibrillator (CRT-D), according to research being presented at the American College of Cardiology’s 62nd Annual Scientific Session.


Lumedx unveiled a host of new HealthView products at the American College of Cardiology Scientific Sessions in San Francisco, March 9-11, 2013. New solutions include a comprehensive, Web-based CVIS with numerous newly released and upgraded components.

 

Siemens Healthcare has announced that the U.S. Food and Drug Administration (FDA) has cleared its Artis Q and Artis Q.zen angiography system families, which feature revolutionary new X-ray tube and detector technology designed to improve minimally invasive therapy of diseases such as coronary artery disease (CAD), stroke and cancer. The new X-ray tube in both the Artis Q and Artis Q.zen can help physicians identify small vessels up to 70 percent better than conventional X-ray tube technology. The Artis Q.zen combines this X-ray source with a new detector technology that supports interventional imaging in ultra-low-dose ranges to patients, doctors and medical staff — particularly during longer interventions. With the Artis Q and Artis Q.zen system families, Siemens Healthcare again demonstrates its innovative strength and market competitiveness — key components of its Agenda 2013 two-year global Sector initiative.

 

Subscribe Now